Clinical Trial Update: A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 clinical study evaluating SHR-A1811 in combination with other therapies for HER2-low advanced or metastatic breast cancer is ongoing, with status c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Advanced or Metastatic Breast Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: HER2 Low Advanced or Metastatic Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN